Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 36.5437.63-0.150.25-0.25

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is 36.54 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202536.54
Mar202437.63
Mar2023-0.15
Mar20220.25
Mar2021-0.25

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 36.54
-2.90
Mar2024 37.63
Positive
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,810.8 Cr 2.8% -6.1% -15.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹99,325.0 Cr 2.6% -7.4% -16.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.8%

-6.1%

-15.7%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses